National Institute on Drug Abuse
* * * * *
- Other Name
- NIDA
- Sponsors Type
- Federal/National
- Country
- United States
- Grant Types
- Fellowship/Scholarship/Dissertation Internship/Work-study Research Project Training/Course Travel Workshop/Conference Post-doctoral Collaboration/Cooperative Agreement Equipment/Facility/Organization Artistic/Exhibit/Collection Publishing/Editorial Other
- Topics
- substance use disorders substance use health disparities substance use treatment hiv community health sciences intervention science overdose prevention opioid use disorder implementation science health equity
Contact Info
- Phone
- 301-443-6441
- Address
- Three White Flint North, 11601 Landsdown Street, North Bethesda, MD 20852
Last modified on 2025-07-31 19:51:53
Description
About NIDA
Our mission is to advance science on drug use and addiction and to apply that knowledge to improve individual and public health.
Sponsor Relationship
National Institute on Drug Abuse is a part of:
No sponsor in our database are part of National Institute on Drug Abuse.
Most Recent Grants from This Sponsors
Funding Opportunity Number: RFA-DA-27-014
This is a Notice of Funding Opportunity (NOFO) for a...
Added on 2026-06-10
Funding Opportunity Number: RFA-DA-27-013
This is a Notice of Funding Opportunity (NOFO) for a...
Added on 2026-06-10
Funding Opportunity Number: PAR-27-026
The National Institute on Drug Abuse (NIDA) Avant-Garde...
Added on 2026-06-09
Funding Opportunity Number: PAS-27-028
The Science Track Award for Research Transition (START)...
Added on 2026-06-09
Deadline Approaching Grants
Funding Opportunity Number: PAR-24-060
**Research Objectives**
The purpose of this notice of...
Deadline on 2026-06-16
Funding Opportunity Number: PAR-24-329
**Background**
Declines in new HIV cases have been...
Deadline on 2026-06-16
Funding Opportunity Number: PA-25-306
The evolution and vitality of the biomedical, behavioral,...
Deadline on 2026-06-16
Funding Opportunity Number: PA-25-307
The evolution and vitality of the biomedical,...
Deadline on 2026-06-16